---
title: "Azora Therapeutics surges 23% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303973016.md"
description: "Azora Therapeutics rose 23.36% to US$4.700. Up 145.81% over six months and down 30.73% from IPO price."
datetime: "2026-11-02T14:34:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303973016.md)
  - [en](https://longbridge.com/en/news/303973016.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303973016.md)
generator: "portal-rs"
---

# Azora Therapeutics surges 23% during regular trading

Azora Therapeutics (AZR.US) surged more than **23%** during regular trading to **$4.70**.

The stock is up 145.81% over the past six months and down 30.73% from its IPO price. It sits 258.78% above its 52-week low of US$1.310.

The Nasdaq Composite is down 2.22% over the past five sessions and up 10.09% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)

## Related News & Research

- [Adial Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Vassiliki Economides](https://longbridge.com/en/news/303813186.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**